Enzyme Discovery Patents: Who Leads, Where the Gaps Are 2026
Enzyme Discovery for Industrial Processes: Patents, Leaders and Open Ground
Five filers hold 60.4% of the field. 162 of 268 records in scope sit with the top five assignees, and the leader alone accounts for 47 records — this is a concentrated space, not a fragmented one. Filings rose to a peak of 10 records in 2020 and have not exceeded that level since. Because publication trails filing by around 18 months, the last one to two years in the chart will always understate real activity — treat the most recent bars as provisional, not as a decline.
- 1BP CORP NORTH AMERICA INC47
- 2BOARD OF RGT UNIV OF NEBRASKA30
- 3MONSANTO TECHNOLOGY LLC30
- 4ALLOZYNE INC29
- 5CALIFORNIA INST OF TECH26
See the full enzyme discovery for industrial processes analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions about this landscape
Who are the leading patent holders in enzyme discovery for industrial processes?
The dataset’s assignee ranking covers 92 companies and research institutions across 268 records, with the top-ranked assignee holding 47 records on its own. The top five combined account for 60.4% of all 268 records in scope, and the top ten reach 88.1%, which means the field is heavily concentrated at the top rather than evenly spread. Several of the leading filers are universities working alongside commercial partners, visible in the co-assignee pairings in the dataset.
Is filing activity in enzyme discovery patents increasing or slowing down?
The recorded trend peaks at 10 records in 2020 and has not exceeded that level in any later year through the current data cut-off. However, patent publication typically lags the actual filing date by around 18 months, so the most recent one to two years in any chart will understate real activity rather than reflect an actual slowdown. A reliable read on 2024-2026 filing levels will not be possible until later publications catch up.
Which patent classification covers the most enzyme discovery filings?
C12N, covering microorganisms and genetic engineering, appears in 76.1% of the 268 records in scope, making it by far the dominant classification. C12P (fermentation and enzymatic synthesis) follows at 20.5%, with G01N (material testing) and C12Q (enzyme/DNA measuring methods) each in the 15-16% range. Because a single record can carry multiple IPC classes, these percentages do not sum to 100% and should each be read against the full 268-record base.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Enzyme Discovery for Industrial Processes covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.